Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Radisson Blu

Oct 25, 2017 8:00 AM - Oct 26, 2017 3:30 PM

Steinentorstrasse 25, 4001 Basel, Switzerland

Value, Access and Regulatory Strategy Workshop

Session 2: Adaptive Pathways and Innovative Medicines Development for Improved Access

Speaker(s)

Jacoline  Bouvy, PHD

Jacoline Bouvy, PHD

Scientific Adviser, Science Policy and Research Programme, National Institute for Health and Care Excellence (NICE), United Kingdom

Adaptive Pathways: An HTA Perspective

Claudine  Sapède, PHARMD

Claudine Sapède, PHARMD

Director, Global HTA Policy, NOVARTIS INTERNATIONAL, Switzerland

Adaptive Pathways: An Industry’s Perspective

Richard  Barker, PHD

Richard Barker, PHD

Founding Director, Centre for the Advancement of Sustainable Medical Innovation (CASMI), United Kingdom

Rosa  Giuliani, MD

Rosa Giuliani, MD

Consultant in Medical Oncology, S. Camillo-Forlanini Hospital, Italy, European Society for Medical Oncology (ESMO), Switzerland

Adaptive Pathways: A Clinician's Perspective

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.